Horizon Blue Cross Blue Shield of New Jersey
11
9M
8
0.12
0.27
- Areas of investment
Summary
The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Newark.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Horizon Blue Cross Blue Shield of New Jersey, startups are often financed by Med-Metrix, Regional Cancer Care Associates, Novartis. The meaningful sponsors for the fund in investment in the same round are Med-Metrix, Regional Cancer Care Associates, Novartis. In the next rounds fund is usually obtained by Boston Millennia Partners, Regional Cancer Care Associates, Novartis.
The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Among the most popular fund investment industries, there are Information Technology, Database. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cota Healthcare.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 0
- Rounds per year
- 0.12
- Follow on index
- 0.27
- Investments by industry
- Health Care (8)
- Life Science (4)
- Biotechnology (4)
- Non Profit (4)
- Communities (2) Show 9 more
- Investments by region
-
- United States (11)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 32
- Group Appearance index
- 0.45
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| COTA Healthcare | 21 Feb 2018 | Biotechnology, Health Care, Life Science | Late Stage Venture | 40M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.